Comprehensive Analysis of NPSR1-AS1 as a Novel Diagnostic and Prognostic Biomarker Involved in Immune Infiltrates in Lung Adenocarcinoma

Table 1

The relationship between NPSR1-AS1 expression and clinicopathological characteristics in patients with LUAD.

Characteristic	Low expression of NPSR1-AS1	High expression of NPSR1-AS1
	267	268
Age, (%)			1.000
≤65	128 (24.8%)	127 (24.6%)
>65	130 (25.2%)	131 (25.4%)
Gender, (%)			0.968
Female	142 (26.5%)	144 (26.9%)
Male	125 (23.4%)	124 (23.2%)
Pathologic stage, (%)			0.244
Stage I	158 (30%)	136 (25.8%)
Stage II	57 (10.8%)	66 (12.5%)
Stage III	36 (6.8%)	48 (9.1%)
Stage IV	12 (2.3%)	14 (2.7%)
Age, median (IQR)	66 (59, 72)	66 (59, 72)	0.616